Programme : Immunotherapeutics and Bioceuticals
Programme Leader : Assoc. Prof. Datin Dr. Hjh. Sharida Fakurazi
The aims of The Immunotherapeutics and Bioceuticals Research Program:
Focuses on the discovery and development of therapies for common and emerging diseases with social and economic impact in animals and humans.
Researches within the program are conducted to seek and develop alternative therapies from natural sources among the enormous biodiversity of Malaysia. The program is also involved in the development of innovative therapies using recombinant proteins and antibodies and drug delivery systems using nano particles. Research activities under the program involve most stages of development of new therapies to include identification, characterization, in vitro and in vivo studies, formulation and product development, using current research tools like PCR, ‘microarray’ and ‘nano particles sizer and zeta potential system’. Ultimately the developed products are intended for commercialization.
-Recieved research grantt about RM35 milions from the Ministry of Science, Technology and Innovation.
-Sophisticated equipment used as a facility for service to researchers both within and outside UPM.
-With a minimum charge imposed
-Income is also available through workshops and seminars organized by the research program
-No. of research grants available – 15 (RM 2,853,300.00)
-No. of articles published - 41 (Total IF = 25.456)
-Human Capital Development (personnel R&D)
-This program is equipped with many sophisticated equipments maintained according to the standards of MS ISO
Updated:: 25/07/2017 [azah]
Institute of Bioscience,
Universiti Putra Malaysia,
43400 UPM Serdang,
Email : firstname.lastname@example.org